EA002481B1 - Композиция на основе солюбилизированного сертралина - Google Patents

Композиция на основе солюбилизированного сертралина Download PDF

Info

Publication number
EA002481B1
EA002481B1 EA199900962A EA199900962A EA002481B1 EA 002481 B1 EA002481 B1 EA 002481B1 EA 199900962 A EA199900962 A EA 199900962A EA 199900962 A EA199900962 A EA 199900962A EA 002481 B1 EA002481 B1 EA 002481B1
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
sertraline
solubilizing agent
concentration
matter
Prior art date
Application number
EA199900962A
Other languages
English (en)
Russian (ru)
Other versions
EA199900962A1 (ru
Inventor
Дуэйн Томас Фризен
Скотт Макс Хербиг
Рави Майсор Шенкер
Джеймс Блэр Вест
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA002481(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900962A1 publication Critical patent/EA199900962A1/ru
Publication of EA002481B1 publication Critical patent/EA002481B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EA199900962A 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина EA002481B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
EA199900962A1 EA199900962A1 (ru) 2000-08-28
EA002481B1 true EA002481B1 (ru) 2002-06-27

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900962A EA002481B1 (ru) 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина

Country Status (34)

Country Link
EP (1) EP0999829A1 (tr)
JP (1) JP2000514100A (tr)
KR (1) KR100366373B1 (tr)
CN (1) CN1261794A (tr)
AP (1) AP1192A (tr)
AR (3) AR015917A1 (tr)
AU (1) AU742535B2 (tr)
BG (1) BG103918A (tr)
BR (1) BR9810739A (tr)
CA (1) CA2290974C (tr)
CO (1) CO4940495A1 (tr)
DZ (1) DZ2548A1 (tr)
EA (1) EA002481B1 (tr)
HN (1) HN1998000102A (tr)
HR (1) HRP980377A2 (tr)
HU (1) HUP0002236A3 (tr)
ID (1) ID23429A (tr)
IL (1) IL133076A (tr)
IS (1) IS5260A (tr)
MA (1) MA24587A1 (tr)
NO (1) NO996520L (tr)
OA (1) OA11243A (tr)
PA (1) PA8454301A1 (tr)
PE (1) PE97199A1 (tr)
PL (1) PL337804A1 (tr)
SK (1) SK181099A3 (tr)
TN (1) TNSN98124A1 (tr)
TR (1) TR199903297T2 (tr)
TW (1) TW550087B (tr)
UA (1) UA67741C2 (tr)
UY (1) UY25071A1 (tr)
WO (1) WO1999001120A1 (tr)
YU (1) YU68299A (tr)
ZA (1) ZA985708B (tr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1738749A1 (en) 1999-12-23 2007-01-03 Pfizer Products Inc. Pharmaceutical compositions providing enhanced drug concentrations
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
AP2001002264A0 (en) 2000-08-30 2001-09-30 Pfizer Prod Inc Sustained release formulations for growth hormone secretagogues.
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
ES2439582T3 (es) * 2007-03-12 2014-01-23 Dsm Ip Assets B.V. Composiciones cosméticas
TW201129557A (en) * 2009-12-29 2011-09-01 Kowa Co Pharmaceutical composition for oral administration
JPWO2011081117A1 (ja) * 2009-12-29 2013-05-09 興和株式会社 経口投与用固形医薬組成物
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
TR199903297T2 (tr) 2000-07-21
CN1261794A (zh) 2000-08-02
OA11243A (en) 2003-07-24
AP9801280A0 (en) 1998-06-30
TNSN98124A1 (fr) 2005-03-15
NO996520D0 (no) 1999-12-28
TW550087B (en) 2003-09-01
PL337804A1 (en) 2000-09-11
NO996520L (no) 2000-02-29
AR015917A1 (es) 2001-05-30
IL133076A (en) 2003-12-10
JP2000514100A (ja) 2000-10-24
UA67741C2 (uk) 2004-07-15
YU68299A (sh) 2002-06-19
UY25071A1 (es) 2000-12-29
AR040280A2 (es) 2005-03-23
IS5260A (is) 1999-11-19
SK181099A3 (en) 2000-07-11
EA199900962A1 (ru) 2000-08-28
HN1998000102A (es) 1999-01-08
CA2290974C (en) 2004-04-27
PA8454301A1 (es) 2000-09-29
AP1192A (en) 2003-07-23
MA24587A1 (fr) 1998-12-31
CO4940495A1 (es) 2000-07-24
WO1999001120A1 (en) 1999-01-14
AU742535B2 (en) 2002-01-03
AU7544898A (en) 1999-01-25
BR9810739A (pt) 2000-09-12
HRP980377A2 (en) 1999-04-30
KR100366373B1 (ko) 2003-01-14
HUP0002236A3 (en) 2003-12-29
IL133076A0 (en) 2001-03-19
PE97199A1 (es) 1999-10-05
AR040279A2 (es) 2005-03-23
DZ2548A1 (fr) 2003-02-08
BG103918A (en) 2000-07-31
KR20010013365A (ko) 2001-02-26
EP0999829A1 (en) 2000-05-17
ID23429A (id) 2000-04-20
CA2290974A1 (en) 1999-01-14
HUP0002236A2 (hu) 2003-08-28
ZA985708B (en) 2000-01-10

Similar Documents

Publication Publication Date Title
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
KR880001090B1 (ko) 디피리다몰의 경구용 제형의 제조방법
US6117453A (en) Solid compositions containing polyethylene oxide and an active ingredient
AU760006B2 (en) Method for making granules with masked taste and instant release of the active particle
KR20180073665A (ko) 심혈관 질환의 치료를 위한 젬카빈 조합
US20110129539A1 (en) Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin
US20070190146A1 (en) Pharmaceutical Multilayer Tablet for Controlled Release of Active Ingredients With Highly pH-Dependent Solubility
CZ288598B6 (cs) Třífázová farmaceutická forma s konstantním a řízeným uvolňováním amorfní účinné složky a způsob její přípravy
JPWO2005092336A1 (ja) 溶出制御製剤とその製造方法
PT2079446E (pt) Formulação de libertação sustida de paliperidona
NL8203343A (nl) Farmaceutisch preparaat.
JP3520924B2 (ja) バルプロ酸金属塩の徐放性錠剤
EA002481B1 (ru) Композиция на основе солюбилизированного сертралина
EA001906B1 (ru) Лекарственные формы с замедленным высвобождением сертралина
JP2002509887A (ja) セファクロル含有徐放性組成物
ES2321908T3 (es) Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
EP0983065A1 (fr) Composition pharmaceutique a residence gastrique
JPH04234812A (ja) 持続性製剤用顆粒
EA028481B1 (ru) Препараты производных пиримидиндиона
EP0447168A2 (en) Long acting granular pharmaceutical composition
IE57220B1 (en) Ph independent controlled releasable tablets
WO2007003746A1 (fr) Formulation a liberation prolongee de principes actifs presentant une solubilite dependante du ph
US20040208926A1 (en) Solubilized sertraline compositions
EP1895990A2 (en) Formulations containing pantoprazole free acid and its salts
NZ501250A (en) Solubilized sertraline compositions